Fulgent Genetics (FLGT) Cash from Investing Activities (QoQ) (2016 - 2026)
Fulgent Genetics (FLGT) Cash from Investing Activities (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Fulgent Genetics | 515.57 Mn | 258.54 Mn | 25.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 364.40% |
| Mar 31, 2026 | -1.93% |
| Dec 31, 2025 | -41.55% |
| Sep 30, 2025 | -64.26% |
| Jun 30, 2025 | 92.59% |
| Mar 31, 2025 | 201.00% |
| Dec 31, 2024 | -405.56% |
| Sep 30, 2024 | 23.01% |
| Jun 30, 2024 | 115.48% |
| Mar 31, 2024 | -294.42% |
| Dec 31, 2023 | 20.88% |
| Sep 30, 2023 | 1,931.93% |
| Jun 30, 2023 | 74.83% |
| Mar 31, 2023 | 95.30% |
| Dec 31, 2022 | -309.08% |
| Sep 30, 2022 | 120.73% |
| Jun 30, 2022 | -31,159.88% |
| Mar 31, 2022 | 100.49% |
| Dec 31, 2021 | -303.12% |
| Sep 30, 2021 | 77.55% |